Companies in the  Consumer Goods sector have received a lot of coverage today as analysts  weigh in on Altria Group (MO – Research Report), Keurig Dr Pepper (KDP – Research Report) and BioVie (BIVI – Research Report). Altria Group (MO) Bank of America Securities analyst Lisa Lewandowski  maintained a Hold rating on Altria Group today and set a price target of $47.00. The company’s shares closed last Thursday at $41.63, close to its 52-week low of $40.91. Lewandowski has an average return of 8.1% when recommending Altria Group.  According to TipRanks.com, Lewandowski is ranked #724 out of 8565 analysts.
		  Altria Group has an analyst consensus of Hold, with a price target consensus of $44.84, which is a 4.7% upside from current levels. In a report issued on October 18, Citi also maintained a Hold rating on the stock with a $45.00 price target. See Insiders’ Hot Stocks on TipRanks >>  Keurig Dr Pepper (KDP) In a report released today, Bryan Spillane  from Bank of America Securities maintained a Buy rating on Keurig Dr Pepper, with a price target of $37.00. The company’s shares closed last Thursday at $30.42. According to TipRanks.com, Spillane is a 4-star analyst with an average return of 2.6% and a 50.2% success rate. Spillane covers the Consumer Goods sector, focusing on stocks such as Coca-Cola Europacific Partners, Mondelez International, and Constellation Brands.
  The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Keurig Dr Pepper with a $35.64 average price target, implying a 22.5% upside from current levels. In a report issued on October 11, UBS also maintained a Buy rating on the stock with a $39.00 price target. BioVie (BIVI) Oppenheimer analyst Jay Olson  maintained a Buy rating on BioVie today and set a price target of $12.00. The company’s shares closed last Thursday at $2.90, close to its 52-week low of $2.68. According to TipRanks.com, Olson is a 5-star analyst with an average return of 7.6% and a 39.4% success rate. Olson covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals, ACADIA Pharmaceuticals, and Enanta Pharmaceuticals. BioVie has an analyst consensus of Moderate Buy, with a price target consensus of $12.00.
		  TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.  Read More on MO:   Indices Commodities Currencies Stocks